SOPHIA GENETICS SA (SOPH) Stock Analyst Ratings
NASDAQ:SOPH - Nasdaq - CH1125843347 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to SOPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.94. This target is 120.89% above the current price.
SOPH was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SOPH.
In the previous month the buy percentage consensus was at a similar level.
SOPH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-18 | Craig-Hallum | Initiate | Buy |
| 2024-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-27 | Guggenheim | Initiate | Buy |
| 2024-03-06 | BTIG | Maintains | Buy -> Buy |
| 2024-03-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-29 | RBC Capital | Initiate | Outperform |
| 2023-05-10 | Credit Suisse | Maintains | Neutral |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-03-08 | Morgan Stanley | Maintains | Overweight |
| 2023-01-03 | BTIG | Initiate | Buy |
| 2022-11-23 | Credit Suisse | Initiate | Neutral |
| 2022-11-09 | Morgan Stanley | Maintains | Overweight |
| 2022-08-10 | Morgan Stanley | Maintains | Overweight |
| 2022-05-11 | Morgan Stanley | Maintains | Overweight |
| 2022-02-15 | Morgan Stanley | Maintains | Overweight |
| 2021-08-17 | Cowen & Co. | Initiate | Outperform |
| 2021-08-17 | JP Morgan | Initiate | Overweight |
| 2021-08-17 | Credit Suisse | Initiate | Outperform |
| 2021-08-17 | Morgan Stanley | Initiate | Overweight |